UNIVEST FINANCIAL Corp Takes $931,000 Position in Xylem Inc. $XYL

UNIVEST FINANCIAL Corp purchased a new stake in Xylem Inc. (NYSE:XYLFree Report) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 7,872 shares of the industrial products company’s stock, valued at approximately $931,000.

Several other institutional investors and hedge funds have also added to or reduced their stakes in XYL. Orion Porfolio Solutions LLC grew its holdings in Xylem by 1.0% during the 3rd quarter. Orion Porfolio Solutions LLC now owns 7,802 shares of the industrial products company’s stock worth $1,151,000 after acquiring an additional 74 shares during the last quarter. Quest Investment Management LLC raised its stake in shares of Xylem by 1.0% in the third quarter. Quest Investment Management LLC now owns 7,588 shares of the industrial products company’s stock worth $1,119,000 after acquiring an additional 77 shares during the last quarter. Notis McConarty Edward raised its stake in shares of Xylem by 0.3% in the fourth quarter. Notis McConarty Edward now owns 31,678 shares of the industrial products company’s stock worth $4,314,000 after acquiring an additional 86 shares during the last quarter. Moneco Advisors LLC lifted its position in shares of Xylem by 4.6% during the fourth quarter. Moneco Advisors LLC now owns 2,049 shares of the industrial products company’s stock worth $279,000 after purchasing an additional 90 shares in the last quarter. Finally, Compound Planning Inc. lifted its position in shares of Xylem by 4.2% during the fourth quarter. Compound Planning Inc. now owns 2,258 shares of the industrial products company’s stock worth $308,000 after purchasing an additional 91 shares in the last quarter. Institutional investors and hedge funds own 87.96% of the company’s stock.

Xylem Stock Performance

XYL stock opened at $117.59 on Tuesday. Xylem Inc. has a twelve month low of $105.29 and a twelve month high of $154.27. The company has a quick ratio of 1.24, a current ratio of 1.61 and a debt-to-equity ratio of 0.23. The company has a market cap of $27.46 billion, a P/E ratio of 28.00, a price-to-earnings-growth ratio of 1.66 and a beta of 1.02. The business’s fifty day moving average is $117.63 and its 200-day moving average is $120.33.

Xylem (NYSE:XYLGet Free Report) last announced its quarterly earnings data on Tuesday, July 28th. The industrial products company reported $1.46 EPS for the quarter, topping analysts’ consensus estimates of $1.34 by $0.12. The business had revenue of $2.34 billion during the quarter, compared to analysts’ expectations of $2.34 billion. Xylem had a return on equity of 11.77% and a net margin of 11.15%.The firm’s quarterly revenue was up 1.5% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.26 earnings per share. Xylem has set its FY 2026 guidance at 5.550-5.700 EPS. Equities research analysts forecast that Xylem Inc. will post 5.67 EPS for the current year.

Xylem Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 24th. Investors of record on Thursday, August 27th will be paid a dividend of $0.43 per share. The ex-dividend date of this dividend is Thursday, August 27th. This represents a $1.72 annualized dividend and a yield of 1.5%. Xylem’s dividend payout ratio (DPR) is presently 40.95%.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the stock. Mizuho raised their price target on shares of Xylem from $124.00 to $130.00 and gave the company a “neutral” rating in a report on Wednesday, July 29th. UBS Group increased their price objective on Xylem from $135.00 to $138.00 and gave the company a “neutral” rating in a research report on Thursday. CLSA raised Xylem to a “hold” rating in a research note on Thursday, June 25th. Oppenheimer dropped their target price on Xylem from $160.00 to $158.00 and set an “outperform” rating for the company in a research report on Wednesday, April 29th. Finally, Barclays upped their price target on Xylem from $154.00 to $159.00 and gave the company an “overweight” rating in a research note on Wednesday, July 29th. Nine research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat, Xylem presently has a consensus rating of “Moderate Buy” and a consensus price target of $154.23.

Get Our Latest Analysis on XYL

Xylem Profile

(Free Report)

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.

See Also

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYLFree Report).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.